Patents by Inventor Steven W. Adams

Steven W. Adams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6017885
    Abstract: IGF and IGFBP are administered to stimulate new bone formation in subjects with bone loss due to bone marrow disorders, connective tissue disorders, drugs, pregnancy, lactation, chronic hypophosphatemia, hyperphosphatasia, insulin-dependent diabetes mellitus, anorexia nervosa, cadmium poisoning, juvenile osteoporosis, Paget's disease of bone, osteoarthritis and periodontal disease. IGF-I and IGFBP-3 are optionally combined with agents that inhibit bone resorption.
    Type: Grant
    Filed: May 14, 1998
    Date of Patent: January 25, 2000
    Assignee: Celtrix Pharmaceuticals, Inc.
    Inventors: Cedo Martin Bagi, Robert Brommage, David M. Rosen, Steven W. Adams
  • Patent number: 5118667
    Abstract: Bone growth factors are used to stimulate new bone formation when administered with agents that inhibit bone resorption. These therapeutic combinations result in an enhanced rate of bone formation with an increase in bone mass.
    Type: Grant
    Filed: May 3, 1991
    Date of Patent: June 2, 1992
    Assignee: Celtrix Pharmaceuticals, Inc.
    Inventors: Steven W. Adams, Rosa Armstrong, David Rosen